AR091192A1 - Procedimiento multicomponente para la preparacion de compuestos biciclicos - Google Patents
Procedimiento multicomponente para la preparacion de compuestos biciclicosInfo
- Publication number
- AR091192A1 AR091192A1 ARP130101870A AR091192A1 AR 091192 A1 AR091192 A1 AR 091192A1 AR P130101870 A ARP130101870 A AR P130101870A AR 091192 A1 AR091192 A1 AR 091192A1
- Authority
- AR
- Argentina
- Prior art keywords
- formula
- branched
- linear
- group
- alkyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C247/00—Compounds containing azido groups
- C07C247/02—Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton
- C07C247/12—Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
- C07C271/06—Esters of carbamic acids
- C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
- C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C271/22—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C291/00—Compounds containing carbon and nitrogen and having functional groups not covered by groups C07C201/00 - C07C281/00
- C07C291/10—Isocyanides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
- C07C309/63—Esters of sulfonic acids
- C07C309/64—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms
- C07C309/65—Esters of sulfonic acids having sulfur atoms of esterified sulfo groups bound to acyclic carbon atoms of a saturated carbon skeleton
- C07C309/66—Methanesulfonates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/52—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring condensed with a ring other than six-membered
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/10—Tetrapeptides
- C07K5/1002—Tetrapeptides with the first amino acid being neutral
- C07K5/1016—Tetrapeptides with the first amino acid being neutral and aromatic or cycloaliphatic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Molecular Biology (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Biophysics (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Abstract
Se describe un procedimiento general, junto con sus posibles variantes, para la producción de los compuestos Telaprevir y Boceprevir. Reivindicación 1: Procedimiento para la preparación de N-acil prolinamidas bicíclicas de fórmula general (1), o sus sales, donde, si n = 0, entonces R⁸ y R⁹ son CH₃, y si n = 1, entonces R⁸ y R⁹ son hidrógeno; comprendiendo dicho procedimiento las siguientes operaciones: a) preparar una d-acilamino-a-hidroxiamida de fórmula (2); b) ciclar una d-acilamino-a-hidroxiamida de fórmula (2) para proporcionar una N-acil prolinamida bicíclica de fórmula (1) de acuerdo con las siguientes etapas: b.1) preparar, partiendo de un compuesto de fórmula (2), una a-activada-d-acilaminoamida de fórmula (3); b.2) ciclar la a-activada-d-acilaminoamida de fórmula (3) para producir la prolinamida de fórmula (1), donde: R² es un resto de fórmula (4); R³ es un resto de fórmula (5), (6) ó (7); R⁵ es alquilo C₁₋₆ lineal o ramificado o un alquilo C₁₋₆ lineal o ramificado sustituido con un alquilo C₁₋₆ cíclico; R¹⁰ es ciclopropilo, o uno de los grupos eliminables del isocianuro convertible; R¹¹ es un grupo saliente capaz de experimentar una sustitución nucleófila; R¹³ es NH₂; NH-Pg; NH-R¹⁴; o un resto de fórmula (8); R¹⁴ es un resto de fórmula (9); R¹⁵ es NH₂; NH-Pg; o NH-R¹⁸; R¹⁶ es OH; OPg; R¹⁷ es hidrógeno o ciclopropilo; R¹⁸ es un resto de fórmula (10); R¹⁹ es OH; un alcoxi C₁₋₆ lineal o ramificado; un alcoxi C₁₋₆ lineal o ramificado sustituido con un arilo C₆₋₁₀; NH-R¹⁰; o NH-R¹⁷; R²⁰ es hidrógeno; un alquilo C₁₋₆ lineal o ramificado; o un alquilo C₁₋₆ lineal o ramificado sustituido con un grupo arilo C₆₋₁₀; y Pg es un grupo protector; en el grupo -OPg en R¹⁶, es un grupo protector alcohol, mientras que en el grupo -NH-Pg en R¹³ o en R¹⁵ es un grupo protector de nitrógeno.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP12382216 | 2012-05-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AR091192A1 true AR091192A1 (es) | 2015-01-21 |
Family
ID=48576982
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ARP130101870 AR091192A1 (es) | 2012-05-30 | 2013-05-29 | Procedimiento multicomponente para la preparacion de compuestos biciclicos |
Country Status (2)
| Country | Link |
|---|---|
| AR (1) | AR091192A1 (es) |
| WO (1) | WO2013178682A2 (es) |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7244721B2 (en) | 2000-07-21 | 2007-07-17 | Schering Corporation | Peptides as NS3-serine protease inhibitors of hepatitis C virus |
| DK1385870T3 (da) * | 2000-07-21 | 2010-07-05 | Schering Corp | Peptider som inhibitorer af NS3-serinprotease fra hepatitis C-virus |
| SV2003000617A (es) | 2000-08-31 | 2003-01-13 | Lilly Co Eli | Inhibidores de la proteasa peptidomimetica ref. x-14912m |
| WO2004113295A1 (en) | 2003-06-17 | 2004-12-29 | Schering Corporation | Process and intermediates for the preparation of (1r,2s,5s)-6,6-dimethyl-3-azabicyclo[3,1,0]hexane-2-carboxylates or salts thereof |
| CN100509784C (zh) | 2003-12-11 | 2009-07-08 | 先灵公司 | 丙型肝炎病毒ns3/ns4a丝氨酸蛋白酶的抑制剂 |
| EP1737821B1 (en) | 2004-02-27 | 2009-08-05 | Schering Corporation | 3,4-(cyclopentyl)-fused proline compounds as inhibitors of hepatitis c virus ns3 serine protease |
| KR20130038947A (ko) | 2005-08-19 | 2013-04-18 | 버텍스 파마슈티칼스 인코포레이티드 | 방법 및 중간체 |
| CN101384551B (zh) | 2005-12-22 | 2012-08-29 | 先灵公司 | 制备6,6-二甲基-3-氮杂双环-[3.1.0]-己烷化合物和其对映体盐的方法 |
| JP2011503231A (ja) * | 2007-11-20 | 2011-01-27 | コンサート ファーマシューティカルズ インコーポレイテッド | Ｈｃｖ感染処置のためのペプチド |
| ES2438576T3 (es) | 2008-06-24 | 2014-01-17 | Codexis, Inc. | Procesos biocatalíticos para la preparación de compuestos de prolina bicíclica fusionada considerablemente pura estereoméricamente |
| BR112012021581A2 (pt) | 2010-02-25 | 2017-03-21 | Ver Voor Christelijk Hoger Onderwijs Wetenschappelijk Onderzoek En Patiëntenzorg | processo de preparação de alfa-aciloxil beta-formamido amidas |
-
2013
- 2013-05-29 WO PCT/EP2013/061073 patent/WO2013178682A2/en active Application Filing
- 2013-05-29 AR ARP130101870 patent/AR091192A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2013178682A3 (en) | 2014-03-13 |
| WO2013178682A2 (en) | 2013-12-05 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY39338A (es) | Derivados de piperidinona como inhibidores mdm2, composiciones farmacéuticas que los contienen y sus usos | |
| CR20140133A (es) | Compuestos de piridazinona y sus usos como inhibidores de daao | |
| CO7240375A2 (es) | Compuestos tricíclicos sustituidos como inhibidores del fgfr | |
| DOP2016000144A (es) | Moduladores de tetrahidropiridopirazinas de gpr6 | |
| CR20120529A (es) | Derivados del acido 1-amino-2-ciclopropiletilboronico | |
| AR092568A1 (es) | Derivados triciclicos de quinolinas y de quinoxalinas | |
| AR088760A1 (es) | Derivados de pirrolopirimidina y purina | |
| ECSP14010763A (es) | Compuestos de ester boronato y composiciones farmaceuticas de los mismos | |
| CR20140042A (es) | Indazoles | |
| AR089774A1 (es) | Derivados de indolizina, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen | |
| PE20151769A1 (es) | Variantes de pertuzumab y su evalaucion | |
| PE20151997A1 (es) | Compuestos heterociclicos y usos de los mismos | |
| SV2014004771A (es) | Nuevos derivados fosfatos, su procedimiento de preparación y las composiciones farmacéuticas que los contienen | |
| AR094167A1 (es) | Composiciones pesticidas y procesos relacionados con ellas | |
| CR20140071A (es) | Nuevos compuestos de 4-piperidinilo para uso como inhibidores de la tankirasa | |
| CO6491087A2 (es) | Compuestos de urea que contienen heteroarilo 5,6 bicíclicos como inhibidores de quinasa | |
| CR20140091A (es) | Nuevos derivados dihidroquinolina-2-ona | |
| UY32704A (es) | Compuestos de 2,3-dihidro-1h-indeno | |
| CR20140535A (es) | Novedosas n-piridinil amidas cíclicas sustituidas como inhibidores de quinasa | |
| CO7111275A2 (es) | Inhibidores de dgat1 de éter cíclico de cabeza de puente | |
| AR098492A1 (es) | Derivados de purina | |
| SV2010003485A (es) | Depsipeptidos ciclicos | |
| CR20130569A (es) | Análogos del ácido epoxieicosatrienoicos y métodos de toma y uso del mismo | |
| EA201590787A1 (ru) | Замещенные пиридопиразины в качестве ингибиторов syk | |
| CR20140322A (es) | Nuevos derivados de bencil sulfonamida útiles como inhibidores de mogat-2 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FB | Suspension of granting procedure |